Microfluidic-based dynamic BH3 profiling predicts anticancer treatment efficacy

Precision medicine is starting to incorporate functional assays to evaluate anticancer agents on patient-isolated tissues or cells to select for the most effective. Among these new technologies, dynamic BH3 profiling (DBP) has emerged and extensively been used to predict treatment efficacy in differ...

Descripción completa

Detalles Bibliográficos
Autores principales: Manzano-Muñoz, Albert, Yeste, José, Ortega, María A., Martín, Fernando, López, Anna, Rosell, Jordi, Castro, Sandra, Serrano, César, Samitier, Josep, Ramón-Azcón, Javier, Montero, Joan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715649/
https://www.ncbi.nlm.nih.gov/pubmed/36456699
http://dx.doi.org/10.1038/s41698-022-00333-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715649/
https://www.ncbi.nlm.nih.gov/pubmed/36456699
http://dx.doi.org/10.1038/s41698-022-00333-0

Ejemplares similares